In specimens obtained from resected pancreata, the intratumoral microvessel density (IMD), the proliferation rate of the neoplastic parenchymal cells, and their p53 protein expression were assessed. The sources of errors were great in the measurements of the IMD. This statement can be illustrated by the finding that when the IMD was calculated by manual counting in five areas of intense neovascularization (hot spot regions), using ×200 and ×400 magnifications, the numbers of microvessels per square millimeter were 65 ± 23 and 106 ± 8, respectively, which reflects a significant difference. Two patterns of microvessel distribution could be identified: one with hot spots only in the stroma (n ‫ס‬ 19) and one in which the hot spots were located in areas of neoplastic parenchyma (including its stroma) (n ‫ס‬ 26). The IMD was significantly greater in the latter group. There was no general correlation of neoplastic disease with the IMD. However, when a scoring system was used to assess the angiogenesis, hot spots in areas of neoplastic parenchyma were associated with a greater proliferation rate of the tumor cells, and with a short length of survival of the patients from their neoplastic disease.
Recently, it has become increasingly evident that angiogenesis (or neovascularization) is an important prerequisite for tumor growth, tumor invasion, and tumor dissemination (1) . The balance between stimuli and inhibitors of angiogenesis determines the extent of vascular outgrowth. Angiogenesis is stimulated by growth factors, such as vascular endothelial growth factor, basic fibroblast growth factor, platelet-derived growth factor, and angiogenin (1) . Conversely, inhibitors of angiogenesis, such as thrombospondin-1, angiostatin, and endostatin, may balance tumor growth by increasing tumor cell apoptosis and preserving tumor cell dormancy (2) (3) (4) . Angiogenesis and tumor invasion are similar processes and may interact (1) . They involve degradation of the basement membrane and migration of cells into the stromal extracellular matrix, during which ligand binding with members of the integrin super family is important (2, (5) (6) (7) . The leaky character of these newly formed vessels (8) facilitates dissemination of tumor cells into the circulation.
Consequently, angiogenesis was recently the subject of intense clinicopathologic and experimental research, mainly to characterize the biologic process, develop prognostic models, and to initiate new therapeutic strategies (7, 9, 10) . Concepts and variables, such as intratumoral microvessel density (IMD), have been launched and calculated in regions of intense neovascularization, so-called hot spots. These calculations have been performed by manual counting or using a computerized image analysis system (CIAS), after visualizing the endothelial cells by immunohistochemical markers (2, 7, 11) . In many of these studies, an inverse correlation was found between the IMD, and the metastatic potential of the neoplastic cells on one hand, and the length of the patient survival time on the other (12) (13) (14) .
In pancreatic duct adenocarcinomas, several cellbiologic prognosticating factors have been studied using DNA-cytometric, immunohistochemical, and morphometric techniques, such as the ploidy pattern of the nuclei of the neoplastic parenchymal cells, their S-phase rate, and their proliferation potency, as well as the incidence of abnormalities in their expression of the p53 protein (15) (16) (17) (18) (19) (20) . However, only a few reports have addressed angiogenesis of the tumor parenchyma as a prognosticating tool in this neoplastic disease (21) (22) (23) .
Given this background, the primary aim of the current study was to characterize the pattern of angiogenesis in specimens of resected pancreas in patients with primary adenocarcinomas of the common desmoplastic ductal type in this gland. Particular attention was paid to determine the IMD and to correlate the pattern and IMD observations with the length of the survival time of the patients. In addition, the angiogenetic data were compared with the results of previously made observations of the same tumor parenchyma with regard to the proliferation rate (Ki-67 antigen expression) and the expression of the p53 protein of the neoplastic cells (15) .
MATERIALS AND METHODS

Patients and tumor material
Paraffin blocks of conventionally formalin-fixed specimens were available from 53 patients with pancreatic duct adenocarcinomas. All the patients had undergone pancreatic duodenal resection at the Surgery Clinic at the Södersjukhuset in Stockholm between 1981 and 1992. The clinicopathologic background of the patients was previously reported (15) . The patients had not received neoadjuvant therapy. The paraffin sections were analyzed immunohistochemically for the expression of the Factor VIII-related antigen. Because of inadequate tumor material in the cut sections, or poor quality of the immunohistochemical sections, eight tumors were excluded.
Thus, the ultimate series of paraffin blocks constituted only those from 45 of these 53 patients. They were 15 men (median age, 65 years; range, 45 to 83 years), and 30 women (median age, 66 years; range, 45 to 83 years). From the same paraffin blocks, sections were also available from previously made immunohistochemical analyses by means of the MIB-1 antiserum against the Ki-67 proliferation antigen and an antiserum detecting the p53 protein expression (15) . Clinical records and follow-up data were present for all 45 patients. Four patients died of causes unrelated to progression of their pancreatic carcinoma, so their data were removed from the survival analysis. The original and newly cut, hematoxylin-andeosin-stained slides were re-evaluated by two of us (M.B. and S.F.). The previously made diagnoses of desmoplastic pancreatic duct adenocarcinomas were confirmed, and the tumor differentiation and the histopathologic malignancy grading were assessed. All tumors were located in the pancreas head. Tumor stage was assessed clinically according to the postsurgical TNM system (24) .
Factor VIII-related antigen immunohistochemical analyses
The avidin-biotin-peroxidase complex technique (Vectastain ABC kit; Vector Laboratories, Burlingame, CA, U.S.A.) was used. The paraffin sections cut were 4 to 5 m thick. Immunoreactivity was enhanced by treatment with pronase for 15 minutes at room temperature. The sections were rinsed in distilled water and incubated with 0.6% hydrogen peroxide for 25 minutes. They were immersed in 1% bovine serum albumin for 30 minutes and incubated overnight at 4°C with primary monoclonal antibodies. The Factor VIII-related mouse monoclonal antibody used (Dako, Glostrup, Denmark) was diluted 1:40. Subsequently, the sections were incubated with biotinylated horse antimouse antibodies for 30 minutes and with the avidin-biotin-peroxidase complex technique for another 30 minutes. Development was made in 3-amino-9-ethyl-carbazol (Sigma Chemical). Sections were counterstained with Mayer hematoxylin.
Ki-67 antigen and p53 protein immunohistochemical analyses
The immunohistochemical procedure for the Ki-67 antigen and that for the p53 protein expression have been described (15) . They were performed according to the same procedure as described before for the Factor VIIIrelated antigen immunohistochemical analysis. The only exception was that, instead of treating the sections with pronase for 15 minutes at room temperature, microwave pretreatment was used. MIB-1 monoclonal antibody (code 0505; Immunotech, Marseille, France), diluted 1:150, which recognizes an epitope of the Ki-67 antigen, and the DO-7 monoclonal antibody (Dako, Glostrup, Denmark), diluted 1:50, which reacts with the wild type and the mutant type of the p53 protein, were used (15) .
Factor VIII-related antigen immunohistochemical evaluations
Only sections with high-quality Factor VIII-related antigen immunohistochemistry (i.e., sections in which a distinct staining was obtained of microvessels and in which the background staining was low) were accepted
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for further assessment. In case the immunohistochemical results were deemed technically unsatisfactory, new sections were prepared. To evaluate the IMD, a technique similar to that described by Weidner (11) was adopted. The individual tumors were soon found to be markedly heterogeneous in their microvessel distribution. By initially scanning the sections at low magnification (×40 or ×100), areas with the highest degree of neovascularization (hot spots) could be identified. For each section, five hot spot areas were chosen, and the IMD was calculated for each of them at both ×200 and ×400 magnifications, corresponding to an area of 0.785 mm 2 and 0.196 mm 2 per field, respectively. The IMD was defined as the number of capillaries and other blood vessels or endotheliumcovered vessel-like structures per square millimeter. The slides were repositioned until the most vessels per epithelial profile were within the ×200 or ×400 fields. An ocular grid facilitated the counting procedure. The IMD values were given for the maximum and the mean of the five hot spots at ×200 and ×400 in each section (max ×200, mean ×200, max ×400, and mean ×400). After checking graphically that the numeric values were distributed approximately normally, the IMD data obtained were expressed as the mean ± SD. The vascular pattern was also evaluated in each case. Two different patterns of vascular distribution were observed, one in which the hot spot areas were within those of the neoplastic parenchyma, including its stroma (Fig.  1A) , and another one in which the areas of hypervascularity were restricted to the stroma only (Fig. 1B) . Accordingly, tumors were classified as positive or negative for the presence of hot spots in the areas of neoplastic parenchyma. The CIAS technique, using the ACAS (Ahrens Cytometry Systems, Bargteheide, Germany) image cytometric system, was also tried (15) . However, it could not distinctly outline all the endothelial structures. An interactive correction proved to be inefficient.
Ki-67 antigen and p53 protein expression immunohistochemical evaluations
The methods applied to evaluate Ki-67 antigen and p53 protein immunohistochemistry have been described (15) . MIB-1 immunoreactivity was investigated using image analysis and the ACAS image cytometric system. The proliferation cell index (PCI), as previously defined (15), and the proliferating cell area (PCA, or the percentage of immunoreactive tumor cell nuclear area) were calculated. The equipment used included a Leitz Orthoplan microscope, plan objective 40/0.95, a single-chip CCD camera (JVC TK 870, Vermont Optechs, Charlotte, VT, U.S.A.), and a color image frame grabber (15) . Using this system, positive 3-amino-9-ethyl-carbazol, reddish-brown tumor cell nuclei could be discriminated from negative 3-amino-9-ethyl-carbazol blue Mayer hematoxylin-stained nuclei. During a calibration phase, the immunoreactive nuclei were defined by the user with respect to the color shade of the staining. During the measuring phase, positive and negative nuclei were recorded automatically; however, an interactive correction was soon needed. In each case, 25 fields within the areas of neoplastic parenchyma were measured. Thus, the fields analyzed were not selected randomly. By this means, purely stromal areas were avoided. Conversely, the measurements were not performed specifically in the most proliferative areas. The goal was to obtain an average estimation. The MIB-1 immunohistochemical data were also evaluated by conventional semiquantitative scoring (15) . The following system was used: −, no staining; (+), clear-cut staining in less than 20% of all the nuclei; +, clear-cut staining up to 40%; ++, clear-cut staining up to 60%; and +++, more than 60% of the nuclei distinctly immunoreactive.
The p53 protein immunoreactivity was scored only conventionally (15) . As in the MIB-1 immunostaining, specimens with only occasional (<1%) weakly immunoreactive nuclei were scored as negative (18) . Negative cases were compared with those with positive scores (+, ++, and +++) in the survival analysis.
Statistics
The unpaired Student t-test was used when values were compared among different groups of patients. Chi- 
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square analysis was applied for differences in the distribution of absolute numbers of patients. The IMD was compared with PCI and PCA by simple regression analyses. The log-rank test was used to assess differences in survival time between groups. Continuous factors were tested for influence on survival, using Cox bivariate regression analysis. Factors that remained significant for survival in the bivariate analysis were also tested in a Cox multivariate regression analysis.
RESULTS
Tumor stage and histopathologic grade
All the tumors fulfilled the histopathologic criteria of being distinctly desmoplastic ductal adenocarcinomas of the common type in the exocrine pancreatic gland. There were 23 stage I, 8 stage II, and 14 stage III tumors. Their median size (i.e., the largest diameter) was 2.5 cm (range, 1 to 7 cm). Four of the adenocarcinomas were considered well differentiated, 15 were moderately well differentiated, and 26 were poorly differentiated.
Factor VIII-related antigen immunoreactivity
As noted previously, IMD was calculated for max ×200, mean ×200, max ×400, and mean ×400. The mean values (± SD) (numbers per square millimeter) were 84 ± 30, 65 ± 23, 142 ± 11, and 106 ± 8, respectively. Thus, the IMD values were significantly greater at ×400 magnification (p < 0.001). In 19 of the tumors, the hypervascular regions (hot spots) were found only in the stroma, whereas in 26 of them hot spots were located in areas of neoplastic parenchyma (including its stroma) (Fig. 1A,B) . Neither the IMD nor the pattern of hot spot distribution was correlated with tumor size, histopathologic grade, or clinical stage. The IMD was greater in the tumors with hot spot areas in the neoplastic parenchyma than in those with hot spots only in the stroma (Table 1) .
Ki-67 immunoreactivity
From 208 to 557 tumor cell nuclei (median, 376) were evaluated in the 45 specimens with MIB-1 immunostaining. The median PCI value was 30% (range, 0.5 to 82%). No correlation was found between PCI and tumor size or histopathologic differentiation grade. According to our semiquantitative scoring, there were two specimens without MIB-1 immunoreactivity, 19 scored as (+), 12 as +, and another 12 as ++. Tumor specimens classified as −/(+) had significantly lower mean PCI values (16 ± 12%) than did those scored as +/++ (42 ± 16%) (p < 0.0001). Thus, there was good agreement between the two methods. The median PCA was 11% (range, 0 to 36%) and tumors scored as −/(+) had lower PCA values (7 ± 7%) than did those scored as +/++ (18 ± 9%) (p < 0.0001).
Immunoreactivity indicating p53 protein expression
The expression of the p53 protein could be assessed immunohistochemically in 40 cases. The neoplastic parenchymal cells displayed clear-cut immunoreactivity for the p53 protein in 17 of them: 3 specimens were classified as +, 9 as ++, and 5 as +++. No immunoreactivity, indicating p53 protein expression, was found in 21 tumors; in the 2 remaining tumors, immunoreactive nuclei were found only occasionally (<1%). Thus, 23 tumors (57%) were classified as p53 negative.
Combination of data from the immunohistochemical analyses of factor VIII-related antigen, Ki-67 antigen, and the p53 protein
In all 45 patients, immunohistochemical data from the studies with the Factor VIII-related antigen and the Ki-67 antigen were available. IMD values in tumors, scored as MIB-1 -or (+), did not differ significantly from those scored as MIB-1 + or ++. Borderline significance (p ‫ס‬ (Table 1) .
Survival analyses
The median overall survival time was 11 months. The results of the Cox bivariate regression analyses showed an inverse relation between tumor size and survival time (p < 0.01). In contrast, neither the TNM tumor stage nor the histopathologic differentiation grade seemed to influence the course of the neoplastic disease (Table 3) . Similarly, the IMD data (max ×200, mean ×200, max ×400, mean ×400) failed to have any prognosticating significance.
However, in patients with tumors in which hot spot regions were located in the stroma only (n ‫ס‬ 19), survival time was longer than in those with hypervascularity in areas of neoplastic parenchyma (n ‫ס‬ 26) (p < 0.01) ( Table 1 ; Fig. 2 ). The prognosis quoad vitam seemed to be better for patients with PCA values less than the median value (11%) than that for patients with values i.e., pancreatic adenocarcinomas, in which the neoplastic parenchymal cells were found to be immunoreactive (vs. non-immunoreactive) with antisera, raised against the protein expressed by the p53 oncogene (n ‫ס‬ 40). 0/1 represents coding for the two patient groups; underlined groups represent a longer survival time; PCI ‫ס‬ proliferating cell index; PCA ‫ס‬ proliferating cell area; IMD ‫ס‬ intratumoral microvessel density.
Relative hazards (RH) and 95% confidence intervals (CI) are given.
FIG. 2.
Patient survival time in relation to the presence (yes) or absence (no) of areas of intense neovascularization (hot spots) in areas of neoplastic parenchyma. In those patients (n ‫ס‬ 26) in whom the newly formed microvessels were in topographically close relation to the adenocarcinoma cells, the prognosis was significantly (p < 0.01) worse than in those patients in whom the hot spot areas were confined to the desmoplastic stroma of the tumor only.
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greater than it (p < 0.05). In contrast, neither the PCI data nor the results of MIB-1 scoring correlated with the length of patient survival.
As noted before, the significant prognosticating markers in the bivariate analysis were also tested in a multivariate analysis. The location of hot spots in areas of neoplastic parenchyma and immunohistochemical data of p53 protein expression were independent prognosticators of short survival time (p < 0.01) ( Table 4) . Table 5 shows some cell-biologic characteristics of the neoplastic parenchyma in long-term survivors. Of these five patients, four were women, and all five had stage I tumors of 3 cm or less. Four tumors had no hot spots in the areas of neoplastic parenchyma, and none of the five adenocarcinomas had tumor cells that expressed the p53 protein. Their MIB-1 patterns were, however, variable.
DISCUSSION
As noted before, only a few reports have addressed immunohistochemical data on angiogenesis as a prognosticating tool in pancreatic carcinoma (21) (22) (23) ). In the current study, some observations were made. To the best of our knowledge, the finding that different types of focal distribution of hypervascularity occur in desmoplastic adenocarcinomas of the exocrine pancreas has not been described before. Nevertheless, the IMD values we obtained were in the same range as those reported from most other laboratories (22, 23) . In our series, the IMD values were greater in tumors with hot spot areas in the neoplastic parenchyma than in those with hot spots only in the desmoplastic stroma of the tumor.
In the current series, the IMD was not related to the prognosis of the patients' neoplastic disease. Ellis et al. (23) also could not find such a correlation. Furthermore, and again as in our study, their IMD data were related neither to the TNM tumor stage nor to the histopathologic differentiation grade. In contrast, in the series of Ikeda et al. (22) , the IMD was reported to be an important prognosticating factor. In our patients, survival time was less for those with carcinomas in which the hot spots were located in areas of the neoplastic parenchyma. Such discrepancies in observations from different laboratories (22, 23) give additional support to the fact that serious important technical sources of errors exist in assessments of angiogenesis in desmoplastic adenocarcinomas.
In mammary carcinomas, several studies have reported a correlation between IMD and the prognosis for the neoplastic disease (12, 14, 25, 26) . McCulloch et al. (27) found a correlation between "tumor cell shedding during breast cancer surgery" and vascular density. The CIAS technique also has been used in mammary carcinomas, and neovascularization, calculated as the percentage of vascular area, was in one study found to be an independent prognosticator (28) . A correlation between short patient survival time and high IMD also was found in colorectal carcinomas (7, 13) . However, contradictory reports exists. Thus, there are results of studies of the angiogenesis in mammary carcinomas without any correlation between the IMD data and the course of the neoplastic disease (29) . In one study of colorectal carcinoma, the results even showed improved survival time in patients with high IMD values (30) .
As accounted for in the results, neither the IMD nor the vascular pattern was related to the ability of the carcinoma to express the p53 protein. We might have expected that a carcinoma, in which neoplastic parenchymal cells were found to be immunoreactive to antisera raised against the p53 protein, would have had more microvessels close to the tumor parenchyma. This presumption is based on the fact that p53 alterations have been reported to down-regulate the angiogenesis inhibitor thrombospondin-1 and to enhance the activity of vascular endothelial growth factor (2). However, other studies in mammary carcinomas found that the IMD was not related to p53 protein expression by the neoplastic parenchymal cells (12, 25, 29) .
In addition, our data on the tumor cell proliferation rate (PCI and PCA) did not correlate with the IMD or the vascular pattern. However, as reflected the results, in those carcinomas in which hot spots were located in areas of neoplastic parenchyma, the proliferation potency of the cancer cells was increased according to the data from the MIB-1scores. Thus, it is of great interest to note that in a series of mammary carcinomas, Vartanian and Weidner (31) calculated a tumor cell Ki-67 index, together with data on IMD, and also an "endothelial cell Ki-67 index" by means of double immunostaining. They a i.e. pancreatic adenocarcinomas, in which the neoplastic parenchymal cells were found to be immunoreactive (vs. non-immunoreactive) with antisera, raised against the protein expressed by the p53 oncogene (n ‫ס‬ 40).
Relative hazards (RH) and 95% confidence intervals (CI).
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found no correlation between the three variables. They concluded that the three variables were regulated by different mechanisms. Other investigators have obtained similar findings (31) (32) (33) (34) . However, in a series of colorectal carcinomas, Vermeulen et al. (35) claimed that a regional differentiation IMD correlated with differences in tumor cell proliferation. These observations correspond with those we made in current study.
It is clear that a high-quality immunohistochemical analysis is crucial for a proper evaluation of the angiogenesis in these desmoplastic adenocarcinomas. The mouse monoclonal antibody to the Factor VIII-related antigen is reported to be a particularly specific panendothelial marker (11) . Nevertheless, in the current series, immunohistochemical analyses had to be repeated, sometimes several times, to achieve technically adequate staining. This problem with the immunostaining has not been particularly underlined by other researchers, although, admittedly, some authors advocate the use of the somewhat more sensitive CD31 antibody (2, 26) . In a study of mammary carcinomas, however, the prognostic information provided by the current mouse monoclonal antibody to the Factor VIII-related antigen was more powerful than that obtained using the CD31 antibody (12) . Antibodies, specific for activated endothelium (CD105), have also been used, but their value as a prognosticating marker is still unclear (36) . The fact that technical difficulties can influence the results of studies of this kind is also illustrated by the recent report in this journal by Kuehn et al. (21) . In contrast to our study, they used the CIAS technique and found a percentage of positive staining per field of 41% in their series of pancreatic carcinomas. This figure seems to us surprisingly high. As noted before, we also tried the CIAS technique but had to abandon it, because the device could not clearly delineate the endothelial structures.
Thus, the calculation of the IMD may depend on several factors beside the choice of the optimally working antibody. First, results depend on the experience of the investigator (26, 29, 37) . Second, selection of blocks and sections used influence the results (38) .Third, there may also be a hetereogeneity within the sections. Thus, an initial, careful scanning at low magnification is needed to localize the hot spot regions (20) . As a matter of fact, in the current series, we soon found that at least five fields had to be selected within each section, because it was difficult by scanning to locate the most active regions. Fourth, the magnification of the microscope chosen is important because, as in the current series, a higher magnification detects more endothelial structures per square millimeter. Similar to the observations made in our series, studies performed in mammary carcinomas have reported a two-fold increase of IMD, using the ×400 magnification as compared to the ×200 (26, 39) . However, the prognosticating value using different magnifications was equal (26) . Fifth, if multiple fields are counted in the same section, as in the current study, it is utterly important to state whether the survival calculations was based on the highest IMD value or on the mean value (12, 13, 29, 40) . As noted, CIAS also has been used in a few angiogenesis studies (21) , but this method is technically demanding and time consuming (28) .
Because tumor growth and tumor metastasis depend on a neovascularization, a histopathologic assessment of the angiogenesis pattern has been used as a target in cancer treatment (9) . In one study, performed in patients with node-negative breast cancer, the IMD was an important prognosticating indicator, and it was proposed that patients at high risk, according to the IMD values, should receive adjuvant therapy (11, 33) . In this context, matrix metalloproteinase inhibitors, used as therapy in patients with pancreatic cancer, are of particular interest because they may block degradation of the extracellular matrix and may also act on angiogenesis (7, 10, 41) . i.e. pancreatic adenocarcinomas, in which the neoplastic parenchymal cells were found to be immunoreactive (vs. non-immunoreactive) with antisera, raised against the protein expressed by the p53 oncogene (n ‫ס‬ 40).
b These two patients died from intercurrent diseases.
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pital, Stockholm, performed many of the statistical calculations.
